Compare CRVO & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVO | NAAS |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3M | 41.7M |
| IPO Year | 2011 | 2017 |
| Metric | CRVO | NAAS |
|---|---|---|
| Price | $3.13 | $3.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 15.7M | 18.9K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $0.60 |
| 52 Week High | $13.13 | $4.54 |
| Indicator | CRVO | NAAS |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 50.46 |
| Support Level | $2.82 | $2.85 |
| Resistance Level | $4.03 | $3.25 |
| Average True Range (ATR) | 0.30 | 0.26 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 20.96 | 39.47 |
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.